What smart money is saying about Geely
0175.HK
No fund has written a full thesis on Geely in our archive, but 1 fund letter reports a position in it, most recently Artemis SmartGARP Global Emerging Markets Equity Fund in December 2025.
Get an email when a fund buys, sells or pitches it
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Geely on record in the archive was reported in Q4 2025, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q4 2025 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position
- December 2025
“Elsewhere, Geely (a Chinese automobile manufacturer) and Sino Biopharm (a pharmaceutical conglomerate in China) came under pressure despite continued progress in their underlying businesses.”
Geely
Read the letters behind these Geely positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger